Novo backs mycoprotein startup MATR to build first factory: ‘We’re not trying to mimic meat’
21 okt. 2025
11:22
Novo Holdings, the investment vehicle of Danish pharma giant Novo Nordisk, has co-led a €40m investment in MATR Foods.
Copenhagen-based MATR Foods has raised €40mn to expand production of its mycoprotein products – which aim not to replace meat but create a new category of fungi-based foods.
The round, split between equity and venture debt, was co-led by Novo Holdings and the Export and Investment Fund of Denmark (EIFO), with support from the European Investment Bank.